Gastric Cancer Clinical Trials Database - Free Access to 838 Studies
Access comprehensive clinical trial information for Gastric Cancer through Pure Global AI's free database. This collection includes 838 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 199 trials are actively recruiting participants.
Research for Gastric Cancer is being conducted in China, Japan, South Korea and 7+ other countries. Leading sponsors include Yonsei University and Fudan University. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Adenocarcinoma
Evaluation of the Efficacy and Safety of Indocyanine Green Tracing in 3D Fluorescent Laparoscopic Lymph Node Dissection for Gastric Cancer
Wecare Study in Gastric Cancer Survivors
FMT+SOX+Sintilimab as First-line Treatment for Advanced Gastric Cancer
Comparative Analysis of Short-Term Therapeutic Effects Between the π-Shaped and Overlap Methods for Esophagogastrostomy in Totally Laparoscopic Total Gastrectomy
Financial Incentives and Motivational Intervention to Improve Gastric Cancer Screening in China
Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients
Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy
Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.
ERAS for Gastric Cancer Patients After NACT
Transhiatal Tunnel Valvuloplasty for Reconstruction Following the Laparoscopic Proximal Gastrectomy
Nab-paclitaxel Combined With Cadonilimab (AK104) for the Second-line Treatment of Advanced Gastric Cancer
A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer.
Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical Application
Systemic Oxidative Stress Score as a Predictor of Gastric Cancer Survival and Recurrence Risk
A Novel Online Calculator to Predict Long-term Survival and Recurrence Risk of Patients With Gastric Adenocarcinoma
Microbiota in Gastric Cancer by Gastric Mucosal Brushing
Metronomic Capecitabine in Stage III Gastric Cancer
Detection of Aneuploidy in Cell Free DNA to Improve the Sensitivity of Diagnostic Peritoneal Lavage in Gastric Cancer
Pepsinogen II and Helicobacter Pylori Test in Gastric Cancer
Pure Global AI provides free access to 838 clinical trials studying Gastric Cancer, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Yonsei University, Fudan University, Hoffmann-La Roche, among others.